Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma

QR Code

Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma

Bibliographic Details
Main Authors:	Brims, Fraser, Meniawy, T., Creaney, J., Lake, R., Nowak, A.
Format:	Conference Paper
Published:	2014
Online Access:	http://hdl.handle.net/20.500.11937/52883

Similar Items

ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)

Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)

A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
by: Brims, Fraser, et al.
Published: (2016)

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)

Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)

Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)

Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)

Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.
by: Jeffery, E., et al.
Published: (2019)

PREDICTION MODELING USING ROUTINE CLINICAL PARAMETERS TO STRATIFY SURVIVAL IN MESOTHELIOMA PATIENTS UNDERGOING SURGERY
by: Harris, E., et al.
Published: (2017)

Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)

Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
by: Brims, Fraser, et al.
Published: (2019)

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
by: Creaney, J., et al.
Published: (2010)

Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)

RESPECT-MESO: AN INTERNATIONAL MULTICENTRE NON-BLINDED RANDOMIZED CONTROLLED TRIAL TO ASSESS THE IMPACT OF REGULAR EARLY SPECIALIST PALLIATIVE CARE IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2017)

Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)

The continual search for ideal biomarkers for mesothelioma: The hurdles
by: Brims, Fraser, et al.
Published: (2013)

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
by: Sneddon, S., et al.
Published: (2015)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)

Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)

Asbestos Related Pleural Diseases
by: Brims, Fraser, et al.
Published: (2016)

SURVIVAL IN MESOTHELIOMA: AN ANALYSIS OF DIFFERENT DIAGNOSTIC TECHNIQUES
by: Muruganandan, S., et al.
Published: (2016)

Validation of an Asbestos Job-Exposure Matrix: Exposure-Response Relationships for Malignant Mesothelioma
by: Kamiya, H., et al.
Published: (2018)

A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)

Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD
by: Asiimwe, A., et al.
Published: (2011)

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
by: Robinson, C., et al.
Published: (2014)

Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)

MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)

Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: A multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters
by: Azzopardi, M., et al.
Published: (2016)

Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)

Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)

Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion
by: Jeffery, E., et al.
Published: (2017)

Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)

Characterisation of genes derived from murine malignant mesothelioma by suppression subtractive hybridization
by: Thean, Ai Lee
Published: (2002)

Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)

The Bacteriology Of Pleural Infection In Western Australia
by: Brims, Fraser, et al.
Published: (2014)

THE BACTERIOLOGY OF PLEURAL INFECTION IN WESTERN AUSTRALIA
by: Brims, Fraser, et al.
Published: (2014)

A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
by: Brims, Fraser, et al.
Published: (2018)

Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
by: Olsen, N., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tl0cfommuq5rbeoatnvv2gsbtv